Month: March 2022

KP Tissue Releases Fourth Quarter and Full Year 2021 Financial Results

Written by Customer Service on March 10, 2022. Posted in Earnings Releases And Operating Results.

Strong topline growth tempered by supply chain and inflation challenges MISSISSAUGA, Ontario, March 10, 2022 (GLOBE NEWSWIRE) — KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2021 and full year 2021 financial and operational results of KPT and Kruger Products L.P. (KPLP). Kruger Products is Canada’s leading manufacturer of quality tissue products for the Consumer market (Cashmere, Purex, SpongeTowels, Scotties, White Swan and Bonterra) and the Away-From-Home (AFH) market, and continues to expand in the U.S. Consumer market with the White Cloud® brand and premium private label products. KPT currently holds a 14.4% interest in KPLP. KPLP Q4 2021 Business and Financial HighlightsRevenue was $424.1 million in Q4 2021 compared to $385.0 million in Q4 2020, an increase of $39.1 million or 10.2%. Adjusted EBITDA1 was $38.3 million...

Galera Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Updates

Written by Customer Service on March 10, 2022. Posted in Earnings Releases And Operating Results.

Positive Phase 3 ROMAN trial of avasopasem for severe oral mucositis met primary and secondary endpoint; Company intends to meet with FDA in 2022 about NDA submission Data readouts from AESOP in esophagitis and GRECO-1 in lung cancer expected in 1H 2022 Strong cash position of $71M with expected cash runway into 2H 2023 MALVERN, Pa., March 10, 2022 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced financial results for the fourth quarter and year ended December 31, 2021 and provided recent corporate updates. “In 2021, we were pleased to report positive data from our lead program evaluating avasopasem for the treatment...

Bioventus Reports Fourth Quarter and Full Year 2021 Financial Results; Introduces Full Year 2022 Financial Guidance

Written by Customer Service on March 10, 2022. Posted in Earnings Releases And Operating Results.

DURHAM, N.C., March 10, 2022 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or “the Company”), a global leader in innovations for active healing, today reported financial results for the fourth quarter and full-year ended December 31, 2021. Fourth Quarter Financial Summary & Recent Highlights:Net Sales of $130.4 million, up $31.8 million, or 32.3%, year over year as reported and 5.1% organically* Net Loss of ($1.9) million, compared to Net Income of $2.3 million in the prior year Adjusted EBITDA* of $28.5 million, compared to $28.2 million in the prior yearFY 2021 Financial Summary:Net Sales of $430.9 million, up $109.7 million, or 34.2%, year over year as reported and 18.8% organically* Net Income of $9.6 million, decreased ($5.1) million, or (34.9%) year over year Adjusted EBITDA*...

Genocea Provides Fourth Quarter 2021 Corporate Update

Written by Customer Service on March 10, 2022. Posted in Earnings Releases And Operating Results.

Initial GEN-011 clinical trial data to be presented at AACR Conference call today at 8:30 a.m. ET CAMBRIDGE, Mass., March 10, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, today provided a business update for the fourth quarter ended December 31, 2021. GEN-011 TiTAN™ trial update Genocea is conducting the Phase I/2a TiTAN clinical trial for its lead program GEN-011, a neoantigen-targeted peripheral T cell (NPT) therapy candidate. GEN-011 is comprised only of CD8+ and CD4+ T cells, extracted from the patient’s peripheral blood and specific for ATLAS-prioritized neoantigens. Patients receive either GEN-011 in multiple fractional doses without lymphodepletion and with intermediate doses of IL-2, or as a single dose after lymphodepletion...

Freight Trucking Market Size [2022-2029] | Industry Trends, Growth, Share and Forecast Analysis

Written by Customer Service on March 10, 2022. Posted in Mergers And Acquisitions.

Growing demand for door-to-door transport and increasing import and export activities of goods and services worldwide to boost the Freight Trucking Market Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The global freight trucking market size is expected to emerge due to the rising demand for door-to-door transport facilities during the projected period. Fortune Business Insights™ publishes this information in an upcoming report titled, Freight Trucking Market, 2021-2029. Freight trucking includes heavy-duty trucks for transporting goods and cargo to long distances. People are inclining towards home delivery services that raise the market’s demand. Gradually rising import/export activities to distribute the goods globally are expected to drive the market in coming years. Report Coverage: The report for the freight trucking...

Liquid Biopsy Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on March 10, 2022. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Liquid Biopsy Market are Biocept, Inc., MDxHealth, F. Hoffmann-La Roche Ltd, Genomic Health, Inc., Bio-Rad Laboratories, Inc., ExoDx. Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The global liquid biopsy market size is set to experience dynamic growth in the forthcoming years owing to the increasing prevalence of different types of cancers across the world, finds Fortune Business Insights™ in its report, titled “Liquid Biopsy Market, 2021-2028”. In recent years, there has been an increasing prevalence of various types of cancers such as lung cancer, stomach cancer, and others among the majority of world population, which has resulted in the rising importance for the medical procedures such as liquid biopsy that proves useful in finding a variety of information about cancer diseases with the...

Parsons to Present at the J.P. Morgan 2022 Industrials Conference

Written by Customer Service on March 10, 2022. Posted in Public Companies.

CENTREVILLE, Va., March 10, 2022 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) announced today that Carey Smith, President and CEO, will present at the J.P. Morgan 2022 Industrials Conference in New York City on Wednesday, March 16, 2022, at approximately 4:40 p.m. Eastern Time. This presentation will be available live via webcast on the investor relations section of Parsons’ website (www.parsons.com). A replay of the webcast also will be available on the website for 30 days. About ParsonsParsons (NYSE: PSN) is a leading disruptive technology provider in the national security and critical infrastructure markets, with capabilities across cybersecurity, missile defense, space, connected infrastructure, and smart cities. Please visit parsons.com, and follow us on LinkedIn and Facebook to learn how we’re making an impact. Media...

Digital Diabetes Management Market Size [2022-2028] | Industry Size, Share, Growth, Trends & Forecast Analysis

Written by Customer Service on March 10, 2022. Posted in Mergers And Acquisitions.

Key Prominent Players Covered in the Digital Diabetes Management Market are Care Innovations, LLC, GlucoMe, Medtronic, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, Dexcom, Inc, Abbott, Insulet Corporation, Bayer AG Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The rising demand for wearable devices is expected to contribute business opportunities for the market, states Fortune Business Insights, in a report, titled Digital Diabetes Management Market Size, Share & Industry Analysis, By Device Type (Hand Held, Wearable), By Product (Smart Glucose Meter, Continuous Glucose Monitoring Systems, Smart Insulin Pens, Smart Insulin Pumps, Others), By End User (Hospitals, Home Healthcare, Others) and Regional Forecast, 2019-2026. The rising cases of diabetes are likely to foster healthy growth of the Digital Diabetes Management Market...

Nasal Spray Market Size [2022-2029] | Industry Growth, Share, Trends, And Global Forecast Analysis

Written by Customer Service on March 10, 2022. Posted in Mergers And Acquisitions.

Rising infections, allergic conditions and advantages offered by nasal sprays driving the growth of Global Nasal Spray Market Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — The Nasal Sprays Market is slated to witness accelerated growth with increasing regulatory approvals for newer products. According to a report by Fortune Business Insights, titled “Nasal Spray Market Size, Share and Global Trend By Type (Salt Water Solutions, Decongestants, Steroid, Antihistamine), By Application (Asthma, Cold, Nasal Allergies), By Patient Type Infant, Paediatric, Adults), By End User (Hospitals, Clinics, Ambulatory Surgery Centres, Home Care Settings) Geography Forecast till 2029,” the market is likely to surge in the coming years with encouragement from increasing FDA approval of newer products. Sample PDF Brochure at https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nasal-spray-market-100273 FDA...

Ride Sharing Market Size to Hit USD 242.73 Billion by 2028 | Exhibit a CAGR of 16.3%

Written by Customer Service on March 10, 2022. Posted in Mergers And Acquisitions.

Rising Demand for Micro mobility and Increasing Penetration of Internet and Smartphones driving the growth of Global Ride Sharing Market Pune, India, March 10, 2022 (GLOBE NEWSWIRE) — Ride Sharing market size is projected to reach USD 242.73 Billion in 2028, at a CAGR of 16.3%. The global Ride Sharing market size was USD 76.48 billion in 2020. The lack of proper public transport systems in the developing nations is expected to entice key players to invest heavily in those regions, thus aiding market growth. The sudden rise in CAGR is attributable to this market’s demand and growth, returning to pre-pandemic levels once the pandemic is over. Industry Developments: May 2021: Bolt Technology OÜ launched a car-sharing service in Estonia. The company also announced its plans to invest EUR 20 million in launching Bolt Drive. Request...

Month: March 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals